Geometric properties of caudate and putamen mark the progression of Huntington’s disease
Imaging Neuroscience · 2026
DOI: 10.1162/imag.a.1351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Imaging Neuroscience, 2026. Verfasst von Dorian Pustina und 6 weiteren Autor:innen. Beteiligte Einrichtung: CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Princeton, NJ, United States. Hauptthemen laut MEDLINE: Huntington Disease, Putamen, Caudate Nucleus. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHDI Foundation.
Abstract (Originalsprache)
Volumetric MRI of the caudate and putamen is a robust biomarker of striatal degeneration in Huntington’s disease (HD). Striatal degeneration may be reflected beyond volume alone, in additional shape and intensity alterations. We evaluated five novel morphometric biomarkers of the caudate and putamen—curvature, flatness, eccentricity, elongation, and focal assessment of divergence estimation (FADE; T1-weighted signal shift)—using cross-sectional and longitudinal MRI data from healthy controls (N = 100), individuals with premanifest HD (preHD; N = 100), and individuals with early manifest HD (earlyHD; N = 100). Geometric measures showed significant cross-sectional group differences with large effect sizes, although volume remained the most sensitive individual biomarker. Longitudinally, most geometric measures detected abnormal rates of change, particularly in the caudate, with medium-to-large effect sizes. The direct comparison between preHD and earlyHD proved challenging for all biomarkers; however, elongation yielded the largest effect size and outperformed volume in this comparison. FADE detected abnormal signal increases in HD groups at baseline but not longitudinally. Power analyses confirmed that volume retains the highest sensitivity, while geometric measures follow closely. Combining volume and geometric measures improved the cross-validated classification accuracy starting at low sample sizes. Correlations between scores and results from atrophy simulations confirmed that HD leaves two signatures on the striatum: loss of volume and loss of shape. While volume remains the strongest standalone biomarker, geometric measures provide complementary information that sharpens disease detection and may enhance biomarker frameworks in future HD clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Princeton, NJ, United States.
- Rancho BioSciences, Rancho Santa Fe, CA, United States.
- Paid consultant, Rancho BioSciences, Rancho Santa Fe, CA, United States.
- Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, United States.
ORCID-Profile: Dorian Pustina, Haikel Bogale, Brian Avants
Förderung
- CHDI Foundation
Zitieren
APA
Pustina, D., Bogale, H., Das, S., Avants, B., Sathe, S., Sampaio, C., & Wood, A. (2026). Geometric properties of caudate and putamen mark the progression of Huntington’s disease. Imaging Neuroscience. https://doi.org/10.1162/imag.a.1351
Vancouver
Pustina D, Bogale H, Das S, Avants B, Sathe S, Sampaio C, et al. Geometric properties of caudate and putamen mark the progression of Huntington’s disease. Imaging Neuroscience. 2026. doi:10.1162/imag.a.1351
BibTeX
@article{Pustina2026,
author = {Pustina, Dorian and Bogale, Haikel and Das, Sandhitsu and Avants, Brian and Sathe, Swati and Sampaio, Cristina and Wood, Andrew},
title = {Geometric properties of caudate and putamen mark the progression of Huntington’s disease},
journal = {Imaging Neuroscience},
year = {2026},
doi = {10.1162/imag.a.1351}
}
EUVIMED